ERLONAT â It contains Drug / Molecules called âErlotiniâb. It belongs to Epidermal Growth Factor Receptor (EGFR) tyrosine kinase inhibitors. The medication works by interfering with the protein epidermal growth factor to prevent it from activating enzymes, cancer cells require these to multiply, grow and spread.
INDICATION:
Erlonat is used for the treatment of advance or metastatic Non-Small Cell Lung cancer.
in stock
Categories: ANTI CANCER, ERLOTINIB